Live Breaking News & Updates on Prevalere Life Sciences

Dr. Mario Rocci Joins The IMA Group as Strategic Advisor in Clinical Research
Share Article
The IMA Group announced today that industry veteran Dr. Mario Rocci has joined the company s Clinical Research division as its new Strategic Advisor. Dr. Rocci will help expand the company s office-based, decentralized and virtual clinical trials.
TARRYTOWN, N.Y. (PRWEB)
January 12, 2021
Mario Rocci, PhD, FCP, FFIP, a seasoned executive with 35 years of scientific and business management experience, has joined The IMA Group (IMA) as Strategic Advisor in the Clinical Research division.
IMA Clinical Research is a network of integrated research sites specializing in Phase II-IV clinical trials in multiple therapeutic areas. IMA performs trials with a flexible model using both their physical locations and virtual capabilities that reach people around the country to support the advancement of safe and eff ....

New York , United States , Mark Weinberger , Mario Rocci , Development Solutions , University Of New York , Government Services , Clinical Research , Prevalere Life Sciences , Payer Services , University At Buffalo , Strategic Advisor , Prevalere Life , Pharmaceutical Sciences , State University , Press Release , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , குறி வெயின்பெர்கர் , மரியோ றோக்ஸி , வளர்ச்சி தீர்வுகள் , பல்கலைக்கழகம் ஆஃப் புதியது யார்க் , அரசு சேவைகள் , மருத்துவ ஆராய்ச்சி , செலுத்துவோர் சேவைகள் , பல்கலைக்கழகம் இல் எருமை ,